{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:37:03Z","timestamp":1786628223848,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:p>\n                    Myxoid inflammatory myofibroblastic sarcoma (MIMS) is a recently described aggressive sarcoma with deceptively bland spindled cells with a myofibroblastic phenotype and myxoid stroma. These tumors are negative for\n                    <jats:italic toggle=\"yes\">ALK<\/jats:italic>\n                    gene rearrangements, but have been shown to harbor gene fusions involving\n                    <jats:italic toggle=\"yes\">PDGFRA\/B<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">JAK1<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">PML<\/jats:italic>\n                    and\/or mutations involving\n                    <jats:italic toggle=\"yes\">KRAS<\/jats:italic>\n                    . Only one uterine case has been previously reported. Here we report the second case of uterine MIMS. This tumor arose in a 40-yr-old woman patient and showed a conspicuously whorled architecture with myxoid stroma and so-called organoid aggregates. By immunohistochemistry, the tumor was positive for CD10, estrogen receptor (ER), and progesterone receptor (PR) with focal smooth muscle actin expression and no staining for ALK, desmin, h-caldesmon, HMB-45, or cathepsin-K. Next-generation sequencing analysis revealed the presence of 2 pathogenic mutations in\n                    <jats:italic toggle=\"yes\">KRAS<\/jats:italic>\n                    , as well as pathogenic mutations in\n                    <jats:italic toggle=\"yes\">RAD51B<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">LATS1<\/jats:italic>\n                    . No gene fusions in\n                    <jats:italic toggle=\"yes\">PDGFRA\/B<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">JAK1<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">PML<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">ALK, ROS1, PLAG1<\/jats:italic>\n                    , or any other gene were identified by whole transcriptomic RNA sequencing. Given its deceptively bland appearance and its propensity, at least in the uterus, to express both CD10 and ER with only focal SMA expression, MIMS can be mistaken for an endometrial stromal tumor, an\n                    <jats:italic toggle=\"yes\">ALK<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">ROS1<\/jats:italic>\n                    -negative uterine inflammatory myofibroblastic tumor, or other cytologically bland fusion-driven uterine mesenchymal neoplasms.\n                  <\/jats:p>","DOI":"10.1097\/pgp.0000000000001192","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T12:01:24Z","timestamp":1779969684000},"page":"395-398","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Uterine Myxoid Inflammatory Myofibroblastic Sarcoma (MIMS) Harboring Pathogenic KRAS Mutations and Expressing ER, PR, and CD10"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0869-0507","authenticated-orcid":false,"given":"Jin","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kushner","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Weisman","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"R1-20260813","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/PAS.0000000000002231","article-title":"Myxoid inflammatory myofibroblastic sarcoma: clinicopathologic analysis of 25 cases of a distinctive sarcoma with deceptively bland morphology and aggressive clinical behavior","volume":"48","author":"Papke","year":"2024","journal-title":"Am J Surg Pathol"},{"key":"R2-20260813","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.18632\/oncotarget.26797","article-title":"Clinical validation of the Tempus xT next-generation targeted oncology sequencing assay","volume":"10","author":"Beaubier","year":"2019","journal-title":"Oncotarget"},{"key":"R3-20260813","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00428-025-04228-w","article-title":"Myxoid inflammatory myofibroblastic sarcoma with multiple liver metastases showing both PML::JAK1 fusion and KRAS mutation","volume":"487","author":"Chen","year":"2025","journal-title":"Virchows Arch"},{"key":"R4-20260813","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/PAS.0000000000002326","article-title":"A high-grade PML::JAK1 fusion sarcoma","volume":"49","author":"Smith","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"R5-20260813","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.bbrc.2019.11.151","article-title":"Novel activating KRAS mutation candidates in lung adenocarcinoma","volume":"522","author":"Abe","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"R6-20260813","doi-asserted-by":"crossref","first-page":"150960","DOI":"10.1155\/2010\/150960","article-title":"Clinical relevance of KRAS in human cancers","volume":"2010","author":"Jancik","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"R7-20260813","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ygyno.2023.07.020","article-title":"Next generation sequencing reveals a high prevalence of pathogenic mutations in homologous recombination DNA damage repair genes among patients with uterine sarcoma","volume":"177","author":"Nasioudis","year":"2023","journal-title":"Gynecol Oncol"},{"key":"R8-20260813","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/PAS.0000000000002094","article-title":"Endometrial\/endometrioid stromal tumors with extensive whorling and CTNNB1 translocation: a report of 3 cases","volume":"47","author":"Boyraz","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"R9-20260813","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00428-026-04420-6","article-title":"CTNNB1 mutation represents a recurrent driver molecular alteration in a subset of endometrial stromal tumors","volume":"488","author":"Dundr","year":"2026","journal-title":"Virchows Arch"},{"key":"R10-20260813","doi-asserted-by":"crossref","first-page":"100552","DOI":"10.1016\/j.modpat.2024.100552","article-title":"PLAG1-rearranged uterine sarcomas: a study of 11 cases showing a wide phenotypical spectrum not limited to myxoid leiomyosarcoma-like morphology","volume":"37","author":"Michal","year":"2024","journal-title":"Mod Pathol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PGP.0000000000001192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:01:18Z","timestamp":1786626078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PGP.0000000000001192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000001192","relation":{},"ISSN":["0277-1691","1538-7151"],"issn-type":[{"value":"0277-1691","type":"print"},{"value":"1538-7151","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"2026-02-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}